GPT and optic nerve disorder: Study treatment-related discontinuation events occurred in 7 patients, which included elevated alanine aminotransferase, hyperkalemia, optic nerve disorder, decreased appetite, accommodation disorder (each in 1 patient); and decreased ejection fraction (2 patients).